BioM Biotech Cluster Development Overview

  • Investor Type
  • Accelerator/​Incubator

  • Status
  • Active

  • Professionals
  • 2


  • Investments
  • 28

  • Portfolio
  • 8

  • Exits
  • 9


BioM Biotech Cluster Development General Information

Company Description

Since 1997, BioM Biotech Cluster Development is an accelerator based in Munich, Germany. The firm focuses on the biotechnology and pharmaceutical sectors.

Business Details

Year Founded
Investor Status
Actively Seeking New Investments
Primary Investor Type
Other Investor Types
Venture Capital
Corporate Office
  • Am Klopferspitz 19a
  • IZB-West, Martinsried
  • 82152 Munich
  • Germany
+49 089 0000000

BioM Biotech Cluster Development Investments (28)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Actarmo Medical 01-Jan-2018 Early Stage VC Laboratory Services (Healthcare) Generating Revenue
advanceCOR 01-Aug-2015 00000 00000 00.000 Drug Discovery Clinical Trials - Phase 2
Aurigon (Pharmaceuticals and Biotechnology) 02-Mar-2015 00000 00000 Other Pharmaceuticals and Biotechnology Generating Revenue 00000000 000000
Pieris Pharmaceuticals 26-Nov-2014 00000 00000 00.000 Drug Discovery Generating Revenue/Not Profitable 00000 000000 00.0
Amcure 15-Jul-2014 00000 00000 00.000 Biotechnology Generating Revenue 00000000 000000
advanceCOR 01-Mar-2013 00000 00000 00.000 Drug Discovery Clinical Trials - Phase 2
Dynamic Biosensors 19-Dec-2012 0000 00000 Electronic Equipment and Instruments Generating Revenue
Corimmun 01-Oct-2010 00000 00000 00.00 Biotechnology Generating Revenue
Kinaxo Biotechnologies 20-Nov-2009 Early Stage VC Drug Discovery Generating Revenue 00000 000000 00.0
Intana BioScience 06-Jul-2009 Seed Round 00000 Discovery Tools (Healthcare) Generating Revenue
You’re viewing 10 of 28 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioM Biotech Cluster Development Exits (9)

Company Name Exit Date Exit Type Exit Size
4SC 13-Jul-2017 Public Investment 2nd Offering 000.00
Pieris Pharmaceuticals 18-Dec-2014 0000000 000000
Corimmun 28-Jun-2012 000000000000000000
Kinaxo Biotechnologies 18-Apr-2011 000000000000000000 0000
U3 Pharma 19-Jun-2008 000000000000000000 00000
Patrys 13-Jul-2007 000 000.00
4SC 15-Dec-2005 000
Switch Biotech 03-Sep-2004 Bankruptcy: Liquidation
Intana BioScience Secondary Transaction - Private
To view BioM Biotech Cluster Development’s complete exits history, request access »

BioM Biotech Cluster Development Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

BioM Biotech Cluster Development Management, Team & Partners (28)

Name Title Deals Funds Boards Office
Ralf Huss Managing Director Munich, Germany
Jens Wiehler Ph.D Managing Director DigiMed Bayern, Digital Health Munich, Germany
Ivonne Wagner Executive, Accounting Munich, Germany
Birgitta von Glass Executive, Marketing & Communications Munich, Germany
Andreas Berghammer Executive, Strategic Management Munich, Germany
You’re viewing 5 of 28 team members. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »